Skip to main content
. 2015 Mar 5;17(2):10.4088/PCC.14m01728. doi: 10.4088/PCC.14m01728

Table 2.

Overall χ2 Test of Compliance for Zolpidem Prescriptions in Women Before and After the US Food and Drug Administration (FDA) Communication

Time Point In Compliance, n (%) Odds Ratio (95% CI) P Value
Post-FDA communication 1,046 (15.5) 1.49 (1.35–1.65) < .0001
Pre-FDA communication 809 (10.9) Reference